Keynote speakers

Prof. Peter Friedl

Dr. Friedl was born and raised in Germany, received his M.D. degree from the University of Bochum in 1992 and the Ph.D. degree from the McGill University, Montreal in 1996. Since 2007 he is directing the Microscopical Imaging Centre of the Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands and since 2011 holds a joint-faculty position at the University of Texas MD Anderson Cancer Center, Houston, TX for preclinical intravital imaging of cancer lesions and their response to molecular targeted and immunotherapy.

His research interest is the mechanisms and plasticity of cell migration in immune regulation and cancer metastasis, with emphasis on cell-matrix adhesion, pericellular proteolysis and cell-cell communication during migration. His laboratory identified pathways determining diversity and plasticity of cell migration, collective cancer cell invasion, and the contribution of migration pathways to immune defense and cancer resistance. His discoveries have provided a nomenclature for the different types of cell migration and their roles in building and (re)shaping tissue, with emphasis on inflammation, regeneration and cancer. His therapeutic preclinical studies focus on the intravital visualization of niches and mechanisms and strategies to overcome therapy resistance.


EACR sponsored keynote speaker Prof. Valerie M Veaver

Valerie M. Weaver, Ph.D., is the Director of the Center for Bioengineering and Tissue Regeneration in the Department of Surgery. She earned her Bachelor of Science degree at the University of Waterloo in Biochemistry/Chemistry in 1985, continuing her education for an Honors Bachelor of Science in Biochemistry at the University of Ottawa (graduating Summa cum Laude). Dr. Weaver earned her doctorate degree, Ph.D, from the University of Ottawa in Biochemistry in 1992.





Prof. Eyal Gottlieb

Dr Gottlieb received his BSc in Agriculture from the Hebrew University and an MSc and a PhD in Molecular Cell Biology from the Weizmann Institute of Science. In 1998 Dr Gottlieb moved as an EMBO fellow to the University of Chicago and later became a Leukemia and Lymphoma Society Special Fellow at the University of Pennsylvania. In 2003, he moved to the Cancer Research-UK, Beatson Institute in Glasgow and was appointed a Professor of Molecular Cell Biology at the University of Glasgow in 2009. Since 2016, Dr Gottlieb is the Laura and Isaac Perlmutter Chair of Cancer Research, Faculty of Medicine, Technion – Israel Institute of Technology, Haifa, Israel.

Dr Gottlieb studies the metabolic adaptations that support tumor growth under metabolic stress. Specifically, he explores vulnerabilities induced by the loss of the metabolic tumor suppressors fumarate hydratase (FH) and succinate dehydrogenase (SDH).